Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 21Unknown 8Terminated 8Recruiting 7Active not recruiting 6Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 44OTHER_GOV 8INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 76Breast Neoplasms 53Colorectal Neoplasms 51Neoplasms 38Advanced Solid Tumors 34Multiple Myeloma 32Prostatic Neoplasms 31Ovarian Neoplasms 28Neoplasm Metastasis 28Recurrence 27Lung Neoplasms 27Carcinoma, Hepatocellular 27Pancreatic Neoplasms 26Advanced Solid Tumor 22Small Cell Lung Carcinoma 20Leukemia, Myeloid, Acute 20Endometrial Neoplasms 19Melanoma 18Triple Negative Breast Neoplasms 16Squamous Cell Carcinoma of Head and Neck 14Lymphoma, Follicular 14Stomach Neoplasms 13Lymphoma, B-Cell 13Glioma 13Glioblastoma 13Uterine Cervical Neoplasms 12Lymphoma 11Head and Neck Neoplasms 11Solid Tumor 10Myasthenia Gravis 9

Interventions

Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Nasopharyngeal Carcinoma × Clear all
NCT05717764 2023-02-08

Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Phase 3 Not yet recruiting
500 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡